Skip to main content
impaact logo Return to homepage
  • Contact
    • Directory
  • About
    • Mission
    • Network Structure
      • Leadership
    • Areas of Research
      • HIV Complications and Co-Morbidities
      • HIV Cure
      • HIV Treatment
      • Tuberculosis
    • Funding Acknowledgements
    • Network Sites
    • Staff Spotlights
  • Studies
    • Research and Study Opportunities
    • Submit a Research Proposal
    • IMPAACT Study Snapshots
  • Community Engagement
    • ICAB Leadership Group
    • IMPAACT Community Advisory Board (ICAB)
    • Operations Center Staff
    • Resources
      • Acronyms
    • Site Community Advisory Boards
    • Community Meetings and Webinars
  • News & Events
    • Events and Conferences
    • IMPAACT Annual Meeting
    • Newsletters
    • Past Conference Presentations
  • Resources
    • COVID-19 Resources
    • HIV/AIDS Network Coordination (HANC)
    • Lab Center
      • Laboratory Committees
      • Laboratory Guidance Documents
      • Laboratory Resources for Quality Management
      • Specimen Repository
    • Manual of Procedures
    • Network Logos & Templates
    • Regulatory Resources
    • Training Opportunities
    • NIH Updates
  • Publications
    • Abstracts
    • Manuscripts
  • Enter a search term.

Breadcrumb

  1. Home
  2. News & Events

News & Events

News

CROI 2022
January 2022

Meetings

IMPAACT at CROI 2022

Main building of the Harvard-Botswana partnership is in Gaborone, Botswana
November 2021

Announcements

IMPAACT Investigator Identifies COVID-19 Omicron Variant

Carol Onyango
November 2021

Announcements

IMPAACT Remembers Carol Onyango

Enter a search term.
Filter

Showing 23 news items.

January 2021
  • Announcements

IMPAACT MOP Updated

January 2021
  • Announcements

IMPAACT at R4P 2021

November 2020
  • Announcements

IMPAACT Award

November 2020
  • Announcements

IMPAACT 2007 informs U.S. FDA approval of two supplements

September 2020
  • Meetings

Key Dates for CROI 2021

June 2020
  • Study Results

IMPAACT P1093 Informs FDA Decision to Approve First-ever Dolutegravir Dispersible Tablet for Treatment of Children living with HIV

June 2020
  • Announcements

Statement from IMPAACT Leadership on Longstanding Racial Injustice

March 2020
  • Meetings

COVID-19 Resources

March 2020
  • Study Results

IMPAACT 2001 Primary Results Released

March 2020
  • Study Results

IMPAACT 2010 Primary Results Released

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page Next
IMPAACT logo Return to homepage

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.

Stay connected with the IMPAACT Network

Follow IMPAACT

Sign up for our newsletter

Sitemap

© 2020 IMPAACT Network